Samrat Pharmachem reports standalone net profit of Rs 2.66 crore in the September 2024 quarter

Net profit of Samrat Pharmachem reported to Rs 2.66 crore in the quarter ended September 2024 as against net loss of Rs 0.19 crore during the previous quarter ended September 2023. Sales declined 12.00% to Rs 70.17 crore in the quarter ended September 2024 as against Rs 79.74 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	70.17	79.74	-12
OPM %	4.80	0.28	-
PBDT	3.69	0.39	846
PBT	3.52	0.23	1430
NP	2.66	-0.19	LP